Surgery Partners (SGRY) Stock Price, News & Analysis

Company Overview

Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers diagnostic imaging, laboratory, obstetrics, oncology, pharmacy, physical therapy, and wound care; and ancillary services, including multi-specialty physician practices, urgent care facilities, and anesthesia services. In addition, it offers single- and multi-specialty facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.

Key Stats

• Today's Range: $21.31 to $21.82
• 50-Day Range: $20.20 to $25.82
• 52-Week Range: $19.50 to $33.97
• Volume: 846,186 shs
• Average Volume: 1.10 million shs
• Market Capitalization: $2.74 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $34.75
• Consensus Rating: Moderate Buy

Surgery Partners Stock Analysis - MarketRank™

Surgery Partners scored higher than 51% of companies evaluated by MarketBeat, and ranked 458th out of 916 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.4 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Surgery Partners has received a consensus rating of Moderate Buy. The company's average rating score is 2.78, and is based on 7 buy ratings, 2 hold ratings, and no sell ratings.

Amount of Analyst Coverage

Surgery Partners has only been the subject of 3 research reports in the past 90 days.

Earnings and Valuation

• Score: 2.5 / 5
• Proj. Earnings Growth: 20.90%

Earnings Growth

Earnings for Surgery Partners are expected to grow by 20.90% in the coming year, from $0.67 to $0.81 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Surgery Partners is -44.75, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Surgery Partners is -44.75, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Growth Ratio

Surgery Partners has a PEG Ratio of 19.21. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Surgery Partners has a P/B Ratio of 0.90. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

13.48% of the float of Surgery Partners has been sold short.

Short Interest Ratio / Days to Cover

Surgery Partners has a short interest ratio ("days to cover") of 7.7.

Change versus previous month

Short interest in Surgery Partners has recently increased by 0.10%, indicating that investor sentiment is decreasing.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Surgery Partners does not currently pay a dividend.

Dividend Growth

Surgery Partners does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

13.48% of the float of Surgery Partners has been sold short.

Short Interest Ratio / Days to Cover

Surgery Partners has a short interest ratio ("days to cover") of 7.7.

Change versus previous month

Short interest in Surgery Partners has recently increased by 0.10%, indicating that investor sentiment is decreasing.

News and Social Media

• Score: 2.0 / 5
• News Sentiment: 0.58

News Sentiment

Surgery Partners has a news sentiment score of 0.58. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.74 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 9 news articles for Surgery Partners this week, compared to 5 articles on an average week.

Search Interest

Only 1 people have searched for SGRY on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Surgery Partners insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $2,717,860.00 in company stock.

Percentage Held by Insiders

Only 2.30% of the stock of Surgery Partners is held by insiders.

SGRY Stock Analysis - Frequently Asked Questions

How have SGRY shares performed this year?

Surgery Partners' stock was trading at $21.17 at the beginning of the year. Since then, SGRY stock has increased by 1.5% and is now trading at $21.48.
View the best growth stocks for 2025 here.

How were Surgery Partners' earnings last quarter?

Surgery Partners, Inc. (NASDAQ:SGRY) announced its quarterly earnings results on Monday, March, 3rd. The company reported $0.39 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.38 by $0.01. The business earned $864.40 million during the quarter, compared to analysts' expectations of $828.09 million. Surgery Partners had a positive trailing twelve-month return on equity of 2.85% and a negative net margin of 2.03%.
Read the conference call transcript.

Who are Surgery Partners' major shareholders?

Surgery Partners' top institutional shareholders include E. Ohman J or Asset Management AB (0.85%), Sivik Global Healthcare LLC (0.10%), Rhumbline Advisers (0.09%) and GAMMA Investing LLC (0.01%). Insiders that own company stock include Andrew T Kaplan, Jason Eric Evans, David T Doherty, Jennifer Baldock, Wayne S Deveydt, Harrison R Bane, Bradley R Owens, Marissa Brittenham, William Trenton Webb, Brent Turner, Laura L Brocklehurst, George Goodwin and Danielle Burkhalter.
View institutional ownership trends.

How do I buy shares of Surgery Partners?

Shares of SGRY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Surgery Partners own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Surgery Partners investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Broadcom (AVGO), Palo Alto Networks (PANW), ServiceNow (NOW) and Adobe (ADBE).

Company Calendar

• Last Earnings: 3/03/2025
• Today: 4/25/2025
• Next Earnings (Estimated): 5/12/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: General medical & surgical hospitals
• Sub-Industry: Healthcare
• Current Symbol: NASDAQ:SGRY
• CIK: 1638833
• Web: www.surgerypartners.com
• Phone: (615) 234-5900
• Fax: 615-234-5998
• Employees: 12,200
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $34.75
• High Stock Price Target: $43.00
• Low Stock Price Target: $28.00
• Potential Upside/Downside: +61.8%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.78
• Research Coverage: 9 Analysts

Profitability

• EPS (Most Recent Fiscal Year): ($1.33)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 32.05
• P/E Growth: 19.21
• Net Income: $-11,900,000.00
• Net Margins: -2.03%
• Pretax Margin: 4.21%
• Return on Equity: 2.85%
• Return on Assets: 1.22%

Debt

• Debt-to-Equity Ratio: 0.99
• Current Ratio: 1.80
• Quick Ratio: 1.66

Sales & Book Value

• Annual Sales: $3.11 billion
• Price / Sales: 0.88
• Cash Flow: $1.50 per share
• Price / Cash Flow: 14.30
• Book Value: $23.99 per share
• Price / Book: 0.90

Miscellaneous

• Outstanding Shares: 127,613,000
• Free Float: 124,190,000
• Market Cap: $2.74 billion
• Optionable: Optionable
• Beta: 2.40